The Enterprise Value as of September 2024 (TTM) for DICE Therapeutics, Inc. (DICE) is 2.21B

According to DICE Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.21B. This represents a change of 73.49% compared to the average of 1.27B of the last 4 quarters.

DICE Therapeutics, Inc. (DICE) Historical Enterprise Value (quarterly & annually)

How has DICE Enterprise Value performed in the past?

The mean historical Enterprise Value of DICE Therapeutics, Inc. over the last ten years is 656.73M. The current 2.21B Enterprise Value has changed 33.55% with respect to the historical average. Over the past ten years (40 quarters), DICE's Enterprise Value was at its highest in in the June 2023 quarter at 2.14B. The Enterprise Value was at its lowest in in the September 2021 quarter at -61943558.00.

DICE Therapeutics, Inc. (DICE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of DICE Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

DICE Therapeutics, Inc. (DICE) Average Enterprise Value

How has DICE Enterprise Value performed in the past?

The current Enterprise Value of DICE Therapeutics, Inc. (DICE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

DICE Therapeutics, Inc. (DICE) Enterprise Value vs. Peers

How is DICE’s Enterprise Value compared to its peers?

DICE Therapeutics, Inc.’s Enterprise Value is less than Nuvalent, Inc. (5.51B), less than Arcellx, Inc. (3.80B), less than Vaxcyte, Inc. (11.96B), greater than Viridian Therapeutics, Inc. (813.50M), greater than Ventyx Biosciences, Inc. (123.69M), greater than Immunocore Holdings plc (1.64B), less than Cytokinetics, Incorporated (6.96B), greater than Edgewise Therapeutics, Inc. (1.60B), less than Karuna Therapeutics, Inc. (12.43B), less than Dyne Therapeutics, Inc. (2.73B), less than Chinook Therapeutics, Inc. (2.61B), greater than Pliant Therapeutics, Inc. (762.35M), less than Crinetics Pharmaceuticals, Inc. (3.78B), less than Ascendis Pharma A/S (6.58B), greater than Terns Pharmaceuticals, Inc. (458.36M), greater than Day One Biopharmaceuticals, Inc. (1.01B), greater than Acumen Pharmaceuticals, Inc. (93.64M), greater than Amylyx Pharmaceuticals, Inc. (89.50M), less than MoonLake Immunotherapeutics (2.55B),

Build a custom stock screener for DICE Therapeutics, Inc. (DICE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DICE Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DICE Therapeutics, Inc. (DICE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DICE Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.